American Society of Hematology

banner image

61st ASH Annual Meeting & Exposition

Register now for the 2019 ASH Annual Meeting! Discounted rates available through October 31.

Learn more
banner image

Visitor Training Program

Learn how to receive 12 weeks of specialized hematology training. Apply to VTP today!

Learn more
banner image

ABIM Announces MOC Reform

ASH President Roy Silverstein, MD, applauded the new assessment options, calling the move a "welcome change" for hematologists.

Learn more

Support Medical Research

Urge your members of Congress to support continued medical research funding.

Take action
Find a Hematologist

Find a Hematologist

Search a database of practicing hematologists in your area.

Learn more
Support Hematology

ASH Foundation

Help move hematology forward by supporting research, career development, and quality care and education programs.

Learn more
Join ASH

ASH Membership

Become part of a global network of more than 17,000 hematologists working to conquer blood diseases.

Learn more
View all press releases
  • CAR T-cell Therapy: An Update on Coverage and Reimbursement

    ASH continues to advocate for adequate coverage and reimbursement for chimeric antigen receptor T-cell (CAR-T) therapy. In early August, the Centers for Medicare and Medicaid Services (CMS) finalized policies impacting both reimbursement of and coverage for CAR-T therapy. The final Inpatient Prospective Payment System (IPPS) rule, published on August 2, and the final Decision Memo for CAR T-cell Therapy for Cancers, issued August 7.

  • 2018 ASH Advocacy Activities

    ASH continues to increase its efforts to expand and enhance the Society’s reach. NIH funding, efforts to ensure patient access to drugs, and sickle cell disease were top priorities on ASH’s advocacy agenda in 2018.

  • 2018 ASH Advocacy Efforts Related to Sickle Cell Disease and Sickle Cell Trait

    ASH continues to invest in and explore the important actions needed to make a significant difference in sickle cell disease (SCD) access to care, research, and global issues. Learn about the major advocacy-related initiatives undertaken by ASH in 2018.

  • 2018 ASH Advocacy Efforts to Ensure Patient Access to Care

    In 2018, ASH worked to ensure patient access to care through a number of methods including ensuring drug access, pain management-related issues, and the Affordable Care Act.

View all policy news
  • Is Hematology Having an Identity Crisis?

    Drs. Naik and Lee discuss the recent hematology workforce study and its significance for the field.

  • The Sickle Cell Clinical Trials Network: One Year In

    The Hematologist Editor-in-Chief, Dr. Laura Michaelis, spoke with Drs. Charles Abrams and Sophie Lanzkron about a groundbreaking ASH initiative started approximately a year ago, the ASH Research Collaborative Sickle Cell Disease Clinical Trials Network.

  • Three Identical Strangers, One Pressing Question

    Dr. Kristen O'Dwyer discusses "Three Identical Strangers," a documentary film about triplet boys born to a single mother and adopted by three separate families, who later learn of each other's existence after a chance encounter and discover they were unwitting participants in a research study.

  • An Unusual Thank-You Letter

    Dr. Stephan Moll provides an update on Charlie the lemur who recently passed away, and shares a thank-you letter sent to him by the Duke Lemur Center.

View all Hematologist articles